Abstract: A method of treating or preventing mastitis in a bovine animal comprising administering to the animal a therapeutically effective amount of particular microbes thereby treating or preventing mastitis in the animal.
Type:
Application
Filed:
March 24, 2020
Publication date:
June 16, 2022
Applicants:
The State of Israel, Ministry of Agriculture&Rural Development, Agricltural Research Oganization(ARO, The State of Israel, Ministry of Agriculture & Rural Development, Kimron Veterinary Institute
Abstract: An isolated polynucleotide is disclosed which comprises a nucleic acid sequence of a Brucella phage, the nucleic acid sequence being specific to the Brucella phage and comprising a sequence selected from the group consisting of SEQ ID NOs: 387-393. An exemplary polynucleotide sequence is one which comprises at least 100 consecutive nucleotides of a nucleic acid sequence as set forth in SEQ ID NO: 396. Uses of such sequences are further disclosed.
Type:
Grant
Filed:
May 11, 2014
Date of Patent:
August 7, 2018
Assignee:
The State of Israel, Ministry of Agriculture & Rural Development, Kimron Veterinary Institute
Abstract: The present invention relates to vaccine compositions comprising attenuated strain of Tilapia Lake Virus (TiLV) for protecting tilapia fish against infection by (TiLV). The invention also relates to methods for using the vaccines to protect tilapines from TiLV-induced disease.
Type:
Grant
Filed:
February 11, 2015
Date of Patent:
August 15, 2017
Assignees:
The State of Israel, Ministry of Agriculture & Rural Development, Kimron Veterinary Institute, Ramot at Tel-Aviv University Ltd.
Abstract: An isolated polynucleotide is disclosed which comprises a nucleic acid sequence of a Brucella phage, the nucleic acid sequence being specific to the Brucella phage and comprising a sequence selected from the group consisting of SEQ ID NOs: 387-393. An exemplary polynucleotide sequence is one which comprises at least 100 consecutive nucleotides of a nucleic acid sequence as set forth in SEQ ID NO: 396. Uses of such sequences are further disclosed.
Type:
Application
Filed:
May 11, 2014
Publication date:
September 4, 2014
Applicant:
The State of Israel, Ministry of Agriculture & Rural Development, Kimron Veterinary Institute
Abstract: An isolated polynucleotide is disclosed which comprises a nucleic acid sequence of a Brucella phage, the nucleic acid sequence being specific to the Brucella phage and comprising a sequence selected from the group consisting of SEQ ID NOs: 387-393. An exemplary polynucleotide sequence is one which comprises at least 100 consecutive nucleotides of a nucleic acid sequence as set forth in SEQ ID NO: 396. Uses of such sequences are further disclosed.
Type:
Grant
Filed:
October 7, 2010
Date of Patent:
May 13, 2014
Assignee:
The State of Israel, Ministry of Agriculture & Rural Development, Kimron Veterinary Institute